Advertisement

Index by author

July 01, 1989; Volume 250,Issue 1

A

  1. Albelda, S M

    1. Pulmonary extraction of propranolol in normal and oxygen-toxic sheep.
      R E Howell, P N Lanken, J H Hansen-Flaschen, F R Haselton, S M Albelda and A P Fishman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 93-99;

  2. Arai, Y

    1. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
      T Tadano, S Satoh, N Satoh, K Kisara, Y Arai, S K Kim and H Kinemuchi
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 254-260;

  3. Ayesta, F J

    1. Tolerance to respiratory actions of sufentanil: functional tolerance and route-dependent differential tolerance.
      F J Ayesta and J Flórez
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 371-378;

B

  1. Bagdy, G

    1. Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats.
      G Bagdy, K Szemeredi, B Kanyicska and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 72-78;

  2. Baron, B M

    1. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
      B M Baron, M W Dudley, D R McCarty, F P Miller, I J Reynolds and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 162-169;

  3. Barone, S

    1. Adenosine receptor prodrugs: towards kidney-selective dialkylxanthines.
      S Barone, P C Churchill and K A Jacobson
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 79-85;

  4. Beaumont, K

    1. Thiazide diuretic receptors: autoradiographic localization in rat kidney with [3H]metolazone.
      K Beaumont, D A Vaughn and D P Healy
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 414-419;

  5. Benishin, C G

    1. Guanine nucleotide binding proteins may modulate gating of calcium channels in vascular smooth muscle. I. Studies with fluoride.
      Y Y Zeng, C G Benishin and P K Pang
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 343-351;
    2. Guanine nucleotide binding proteins may modulate gating of calcium channels in vascular smooth muscle. II. Studies with guanosine 5'-(gamma)triphosphate.
      Y Y Zeng, C G Benishin and P K Pang
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 352-357;

  6. Bennett, B M

    1. Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines.
      B M Bennett, D C Leitman, H Schröder, J H Kawamoto, K Nakatsu and F Murad
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 316-323;

  7. Berger, H

    1. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels.
      T D Bjornsson, D E Schneider and H Berger
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 154-161;

  8. Bertrand, C

    1. Characterization of muscarinic receptors in human, guinea pig and rat lung.
      J P Gies, C Bertrand, P Vanderheyden, F Waeldele, P Dumont, G Pauli and Y Landry
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 309-315;

  9. Bickel, W K

    1. Drug discrimination in human postaddicts: agonist-antagonist opioids.
      K L Preston, G E Bigelow, W K Bickel and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 184-196;

  10. Bigelow, G E

    1. Drug discrimination in human postaddicts: agonist-antagonist opioids.
      K L Preston, G E Bigelow, W K Bickel and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 184-196;

  11. Billings, J

    1. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
      B S Schonwetter, R R Luedtke, M P Kung, J Billings, H F Kung and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 110-116;

  12. Bjornsson, T D

    1. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels.
      T D Bjornsson, D E Schneider and H Berger
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 154-161;

  13. Bobker, D H

    1. Serotonin agonists inhibit synaptic potentials in the rat locus ceruleus in vitro via 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors.
      D H Bobker and J T Williams
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 37-43;

  14. Borosky, S

    1. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
      J W Ferkany, D J Kyle, J Willets, W J Rzeszotarski, M E Guzewska, S R Ellenberger, S M Jones, A I Sacaan, L D Snell and S Borosky
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 100-109;

  15. Bronner, C

    1. Activation of rat peritoneal mast cells by substance P and mastoparan.
      M Mousli, C Bronner, J L Bueb, E Tschirhart, J P Gies and Y Landry
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 329-335;

  16. Bueb, J L

    1. Activation of rat peritoneal mast cells by substance P and mastoparan.
      M Mousli, C Bronner, J L Bueb, E Tschirhart, J P Gies and Y Landry
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 329-335;

C

  1. Cavero, I

    1. Evidence for the existence and ionic modulation of platelet-activating factor receptors mediating degranulatory responses in human polymorphonuclear leukocytes.
      O Marquis, C Robaut and I Cavero
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 293-300;

  2. Chen, J C

    1. Increased serotonin efflux by a partially oxidized serotonin: tryptamine-4,5-dione.
      J C Chen, P B Crino, P W Schnepper, A C To and L Volicer
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 141-148;

  3. Cho, A K

    1. Pharmacokinetic and pharmacodynamic evaluation of phencyclidine and its decadeutero variant.
      A K Cho, M Hiramatsu, R N Pechnick and E Di Stefano
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 210-215;

  4. Churchill, P C

    1. Adenosine receptor prodrugs: towards kidney-selective dialkylxanthines.
      S Barone, P C Churchill and K A Jacobson
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 79-85;

  5. Clemens, J A

    1. Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist.
      M M Foreman, R W Fuller, M D Hynes, J S Gidda, C L Nichols, J M Schaus, E C Kornfeld and J A Clemens
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 227-235;

  6. Cook, N S

    1. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
      U Quast and N S Cook
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 261-271;

  7. Cornfeldt, M

    1. Characterization of the discriminative stimulus effects of physostigmine in the rat.
      K W Locke, B Gorney, M Cornfeldt and S Fielding
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 241-246;

  8. Crino, P B

    1. Increased serotonin efflux by a partially oxidized serotonin: tryptamine-4,5-dione.
      J C Chen, P B Crino, P W Schnepper, A C To and L Volicer
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 141-148;

  9. Cubeddu, L X

    1. Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum.
      D M Niedzwiecki, L X Cubeddu and R B Mailman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 117-125;
    2. Comparative anticholinergic properties of thioridazine, mesoridazine and sulforidazine.
      D M Niedzwiecki, L X Cubeddu and R B Mailman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 126-133;

D

  1. Deutsch, J C

    1. Structural specificity of mechanisms controlling the hepatic uptake and biliary output of methotrexate in the rat.
      J C Deutsch and J F Kolhouse
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 221-226;

  2. Di Stefano, E

    1. Pharmacokinetic and pharmacodynamic evaluation of phencyclidine and its decadeutero variant.
      A K Cho, M Hiramatsu, R N Pechnick and E Di Stefano
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 210-215;

  3. Dudley, M W

    1. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
      B M Baron, M W Dudley, D R McCarty, F P Miller, I J Reynolds and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 162-169;

  4. Dulaney, M D

    1. Changes in drinking activity, urine volume and urinary electrolyte excretion after intracerebroventricular administration of diisopropylfluorophosphate.
      M D Dulaney, R W Rockhold, A C Porter, B Hoskins and I K Ho
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 202-209;

  5. Dumont, P

    1. Characterization of muscarinic receptors in human, guinea pig and rat lung.
      J P Gies, C Bertrand, P Vanderheyden, F Waeldele, P Dumont, G Pauli and Y Landry
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 309-315;

E

  1. Ehrenberg, B L

    1. Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam.
      D J Greenblatt, B L Ehrenberg, J Gunderman, J M Scavone, N T Tai, J S Harmatz and R I Shader
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 134-140;

  2. Elías, M M

    1. Vulnerability of the thick ascending limb to glutathione depletion in rat kidney: effects of diuretics and indomethacin.
      A M Torres, J V Rodriguez and M M Elías
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 247-253;

  3. Ellenberger, S R

    1. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
      J W Ferkany, D J Kyle, J Willets, W J Rzeszotarski, M E Guzewska, S R Ellenberger, S M Jones, A I Sacaan, L D Snell and S Borosky
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 100-109;

F

  1. Fan, Z

    1. Activation of ATP-sensitive outward K+ current by nicorandil (2-nicotinamidoethyl nitrate) in isolated ventricular myocytes.
      M Hiraoka and Z Fan
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 278-285;

  2. Ferkany, J W

    1. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
      J W Ferkany, D J Kyle, J Willets, W J Rzeszotarski, M E Guzewska, S R Ellenberger, S M Jones, A I Sacaan, L D Snell and S Borosky
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 100-109;

  3. Fielding, S

    1. Characterization of the discriminative stimulus effects of physostigmine in the rat.
      K W Locke, B Gorney, M Cornfeldt and S Fielding
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 241-246;

  4. Fishman, A P

    1. Pulmonary extraction of propranolol in normal and oxygen-toxic sheep.
      R E Howell, P N Lanken, J H Hansen-Flaschen, F R Haselton, S M Albelda and A P Fishman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 93-99;

  5. Flórez, J

    1. Tolerance to respiratory actions of sufentanil: functional tolerance and route-dependent differential tolerance.
      F J Ayesta and J Flórez
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 371-378;

  6. Foreman, M M

    1. Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist.
      M M Foreman, R W Fuller, M D Hynes, J S Gidda, C L Nichols, J M Schaus, E C Kornfeld and J A Clemens
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 227-235;

  7. France, C P

    1. Analgesic effects of phencyclidine-like drugs in rhesus monkeys.
      C P France, A M Snyder and J H Woods
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 197-201;

  8. Frenken, M

    1. Evidence for two populations of 5-hydroxytryptamine receptors in dog basilar artery.
      M Frenken
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 379-387;

  9. Fuller, R W

    1. Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist.
      M M Foreman, R W Fuller, M D Hynes, J S Gidda, C L Nichols, J M Schaus, E C Kornfeld and J A Clemens
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 227-235;

  10. Fusetani, N

    1. Calcium-independent activation of contractile apparatus in smooth muscle by calyculin-A.
      H Ishihara, H Ozaki, K Sato, M Hori, H Karaki, S Watabe, Y Kato, N Fusetani, K Hashimoto and D Uemura
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 388-396;

G

  1. Gessner, G

    1. Studies defining minimal receptor domains for angiotensin II.
      R G Pendleton, G Gessner and E Horner
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 31-36;

  2. Gidda, J S

    1. Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist.
      M M Foreman, R W Fuller, M D Hynes, J S Gidda, C L Nichols, J M Schaus, E C Kornfeld and J A Clemens
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 227-235;

  3. Gies, J P

    1. Characterization of muscarinic receptors in human, guinea pig and rat lung.
      J P Gies, C Bertrand, P Vanderheyden, F Waeldele, P Dumont, G Pauli and Y Landry
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 309-315;
    2. Activation of rat peritoneal mast cells by substance P and mastoparan.
      M Mousli, C Bronner, J L Bueb, E Tschirhart, J P Gies and Y Landry
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 329-335;

  4. Gorney, B

    1. Characterization of the discriminative stimulus effects of physostigmine in the rat.
      K W Locke, B Gorney, M Cornfeldt and S Fielding
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 241-246;

  5. Greenblatt, D J

    1. Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam.
      D J Greenblatt, B L Ehrenberg, J Gunderman, J M Scavone, N T Tai, J S Harmatz and R I Shader
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 134-140;

  6. Gunderman, J

    1. Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam.
      D J Greenblatt, B L Ehrenberg, J Gunderman, J M Scavone, N T Tai, J S Harmatz and R I Shader
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 134-140;

  7. Guzewska, M E

    1. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
      J W Ferkany, D J Kyle, J Willets, W J Rzeszotarski, M E Guzewska, S R Ellenberger, S M Jones, A I Sacaan, L D Snell and S Borosky
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 100-109;

H

  1. Haleen, S J

    1. PD 122860: a novel dihydropyridine with sodium channel stimulating and calcium channel blocking properties.
      S J Haleen, R P Steffen, I Sircar, T C Major, M D Taylor, T A Pugsley and R E Weishaar
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 22-30;

  2. Hanano, M

    1. Transport of cefodizime, a novel third generation cephalosporin antibiotic, in isolated rat choroid plexus.
      T Nohjoh, H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 324-328;

  3. Hansen-Flaschen, J H

    1. Pulmonary extraction of propranolol in normal and oxygen-toxic sheep.
      R E Howell, P N Lanken, J H Hansen-Flaschen, F R Haselton, S M Albelda and A P Fishman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 93-99;

  4. Harmatz, J S

    1. Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam.
      D J Greenblatt, B L Ehrenberg, J Gunderman, J M Scavone, N T Tai, J S Harmatz and R I Shader
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 134-140;

  5. Haselton, F R

    1. Pulmonary extraction of propranolol in normal and oxygen-toxic sheep.
      R E Howell, P N Lanken, J H Hansen-Flaschen, F R Haselton, S M Albelda and A P Fishman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 93-99;

  6. Hashimoto, K

    1. Calcium-independent activation of contractile apparatus in smooth muscle by calyculin-A.
      H Ishihara, H Ozaki, K Sato, M Hori, H Karaki, S Watabe, Y Kato, N Fusetani, K Hashimoto and D Uemura
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 388-396;

  7. Healy, D P

    1. Thiazide diuretic receptors: autoradiographic localization in rat kidney with [3H]metolazone.
      K Beaumont, D A Vaughn and D P Healy
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 414-419;

  8. Heaslip, R J

    1. Evidence that prostaglandins can contract the rat aorta via a novel protein kinase C-dependent mechanism.
      R J Heaslip and B D Sickels
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 44-51;

  9. Hiramatsu, M

    1. Pharmacokinetic and pharmacodynamic evaluation of phencyclidine and its decadeutero variant.
      A K Cho, M Hiramatsu, R N Pechnick and E Di Stefano
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 210-215;

  10. Hiraoka, M

    1. Activation of ATP-sensitive outward K+ current by nicorandil (2-nicotinamidoethyl nitrate) in isolated ventricular myocytes.
      M Hiraoka and Z Fan
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 278-285;

  11. Ho, I K

    1. Changes in drinking activity, urine volume and urinary electrolyte excretion after intracerebroventricular administration of diisopropylfluorophosphate.
      M D Dulaney, R W Rockhold, A C Porter, B Hoskins and I K Ho
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 202-209;

  12. Hori, M

    1. Calcium-independent activation of contractile apparatus in smooth muscle by calyculin-A.
      H Ishihara, H Ozaki, K Sato, M Hori, H Karaki, S Watabe, Y Kato, N Fusetani, K Hashimoto and D Uemura
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 388-396;

  13. Horner, E

    1. Studies defining minimal receptor domains for angiotensin II.
      R G Pendleton, G Gessner and E Horner
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 31-36;

  14. Hoskins, B

    1. Changes in drinking activity, urine volume and urinary electrolyte excretion after intracerebroventricular administration of diisopropylfluorophosphate.
      M D Dulaney, R W Rockhold, A C Porter, B Hoskins and I K Ho
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 202-209;

  15. Howell, R E

    1. Pulmonary extraction of propranolol in normal and oxygen-toxic sheep.
      R E Howell, P N Lanken, J H Hansen-Flaschen, F R Haselton, S M Albelda and A P Fishman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 93-99;

  16. Hyman, A L

    1. Adenosine does not mediate the pulmonary vasodilator response of adenosine 5'-triphosphate in the feline pulmonary vascular bed.
      C F Neely, P J Kadowitz, H Lippton, M Neiman and A L Hyman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 170-176;

  17. Hynes, M D

    1. Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist.
      M M Foreman, R W Fuller, M D Hynes, J S Gidda, C L Nichols, J M Schaus, E C Kornfeld and J A Clemens
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 227-235;

I

  1. Iga, T

    1. Transport of cefodizime, a novel third generation cephalosporin antibiotic, in isolated rat choroid plexus.
      T Nohjoh, H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 324-328;

  2. Ishihara, H

    1. Calcium-independent activation of contractile apparatus in smooth muscle by calyculin-A.
      H Ishihara, H Ozaki, K Sato, M Hori, H Karaki, S Watabe, Y Kato, N Fusetani, K Hashimoto and D Uemura
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 388-396;

  3. Ito, H

    1. Calmodulin and free oxygen radicals interaction with steady-state calcium accumulation and passive calcium permeability of cardiac sarcoplasmic reticulum.
      E Okabe, M Sugihara, K Tanaka, H Sasaki and H Ito
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 286-292;

  4. Iuvone, P M

    1. Catecholamine receptors regulating serotonin N-acetyltransferase activity and melatonin content of chicken retina and pineal gland: D2-dopamine receptors in retina and alpha-2 adrenergic receptors in pineal gland.
      J Zawilska and P M Iuvone
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 86-92;

J

  1. Jackson, E K

    1. Defective modulation of noradrenergic neurotransmission by endogenous prostaglandins in aging spontaneously hypertensive rats.
      E K Jackson
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 9-21;

  2. Jacobson, K A

    1. Adenosine receptor prodrugs: towards kidney-selective dialkylxanthines.
      S Barone, P C Churchill and K A Jacobson
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 79-85;

  3. Jones, S M

    1. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
      J W Ferkany, D J Kyle, J Willets, W J Rzeszotarski, M E Guzewska, S R Ellenberger, S M Jones, A I Sacaan, L D Snell and S Borosky
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 100-109;

  4. Josepovitz, C

    1. Polyaspartic acid protects against gentamicin nephrotoxicity in the rat.
      L S Ramsammy, C Josepovitz, B P Lane and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 149-153;

K

  1. Kadowitz, P J

    1. Adenosine does not mediate the pulmonary vasodilator response of adenosine 5'-triphosphate in the feline pulmonary vascular bed.
      C F Neely, P J Kadowitz, H Lippton, M Neiman and A L Hyman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 170-176;

  2. Kalichman, M W

    1. Quantitative histologic analysis of local anesthetic-induced injury to rat sciatic nerve.
      M W Kalichman, H C Powell and R R Myers
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 406-413;

  3. Kaloyanides, G J

    1. Polyaspartic acid protects against gentamicin nephrotoxicity in the rat.
      L S Ramsammy, C Josepovitz, B P Lane and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 149-153;

  4. Kanyicska, B

    1. Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats.
      G Bagdy, K Szemeredi, B Kanyicska and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 72-78;

  5. Karaki, H

    1. Calcium-independent activation of contractile apparatus in smooth muscle by calyculin-A.
      H Ishihara, H Ozaki, K Sato, M Hori, H Karaki, S Watabe, Y Kato, N Fusetani, K Hashimoto and D Uemura
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 388-396;

  6. Kato, Y

    1. Calcium-independent activation of contractile apparatus in smooth muscle by calyculin-A.
      H Ishihara, H Ozaki, K Sato, M Hori, H Karaki, S Watabe, Y Kato, N Fusetani, K Hashimoto and D Uemura
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 388-396;

  7. Kawamoto, J H

    1. Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines.
      B M Bennett, D C Leitman, H Schröder, J H Kawamoto, K Nakatsu and F Murad
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 316-323;

  8. Kim, S K

    1. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
      T Tadano, S Satoh, N Satoh, K Kisara, Y Arai, S K Kim and H Kinemuchi
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 254-260;

  9. Kinemuchi, H

    1. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
      T Tadano, S Satoh, N Satoh, K Kisara, Y Arai, S K Kim and H Kinemuchi
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 254-260;

  10. Kisara, K

    1. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
      T Tadano, S Satoh, N Satoh, K Kisara, Y Arai, S K Kim and H Kinemuchi
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 254-260;

  11. Kitada, Y

    1. Potent stimulation of myofilament force and adenosine triphosphatase activity of canine cardiac muscle through a direct enhancement of troponin C Ca++ binding by MCI-154, a novel cardiotonic agent.
      Y Kitada, M Kobayashi, A Narimatsu and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 272-277;

  12. Kobayashi, M

    1. Potent stimulation of myofilament force and adenosine triphosphatase activity of canine cardiac muscle through a direct enhancement of troponin C Ca++ binding by MCI-154, a novel cardiotonic agent.
      Y Kitada, M Kobayashi, A Narimatsu and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 272-277;

  13. Kolhouse, J F

    1. Structural specificity of mechanisms controlling the hepatic uptake and biliary output of methotrexate in the rat.
      J C Deutsch and J F Kolhouse
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 221-226;

  14. Kornfeld, E C

    1. Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist.
      M M Foreman, R W Fuller, M D Hynes, J S Gidda, C L Nichols, J M Schaus, E C Kornfeld and J A Clemens
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 227-235;

  15. Kudlacz, E M

    1. Phosphatidic acid phosphatase in neonatal rat lung: effects of prenatal dexamethasone or terbutaline treatment on basal activity and on responsiveness to beta adrenergic stimulation.
      E M Kudlacz, H A Navarro and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 236-240;

  16. Kung, H F

    1. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
      B S Schonwetter, R R Luedtke, M P Kung, J Billings, H F Kung and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 110-116;

  17. Kung, M P

    1. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
      B S Schonwetter, R R Luedtke, M P Kung, J Billings, H F Kung and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 110-116;

  18. Kyle, D J

    1. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
      J W Ferkany, D J Kyle, J Willets, W J Rzeszotarski, M E Guzewska, S R Ellenberger, S M Jones, A I Sacaan, L D Snell and S Borosky
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 100-109;

L

  1. Landry, Y

    1. Characterization of muscarinic receptors in human, guinea pig and rat lung.
      J P Gies, C Bertrand, P Vanderheyden, F Waeldele, P Dumont, G Pauli and Y Landry
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 309-315;
    2. Activation of rat peritoneal mast cells by substance P and mastoparan.
      M Mousli, C Bronner, J L Bueb, E Tschirhart, J P Gies and Y Landry
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 329-335;

  2. Lane, B P

    1. Polyaspartic acid protects against gentamicin nephrotoxicity in the rat.
      L S Ramsammy, C Josepovitz, B P Lane and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 149-153;

  3. Lanken, P N

    1. Pulmonary extraction of propranolol in normal and oxygen-toxic sheep.
      R E Howell, P N Lanken, J H Hansen-Flaschen, F R Haselton, S M Albelda and A P Fishman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 93-99;

  4. Leitman, D C

    1. Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines.
      B M Bennett, D C Leitman, H Schröder, J H Kawamoto, K Nakatsu and F Murad
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 316-323;

  5. Li, A A

    1. Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule.
      G J Marek, A A Li and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 52-59;
    2. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
      G J Marek, A A Li and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 60-71;

  6. Liebson, I A

    1. Drug discrimination in human postaddicts: agonist-antagonist opioids.
      K L Preston, G E Bigelow, W K Bickel and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 184-196;

  7. Lippton, H

    1. Adenosine does not mediate the pulmonary vasodilator response of adenosine 5'-triphosphate in the feline pulmonary vascular bed.
      C F Neely, P J Kadowitz, H Lippton, M Neiman and A L Hyman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 170-176;

  8. Locke, K W

    1. Characterization of the discriminative stimulus effects of physostigmine in the rat.
      K W Locke, B Gorney, M Cornfeldt and S Fielding
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 241-246;

  9. Luedtke, R R

    1. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
      B S Schonwetter, R R Luedtke, M P Kung, J Billings, H F Kung and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 110-116;

  10. Luo, Z P

    1. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate.
      X M Yang, Z P Luo and J H Zhou
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 358-363;

M

  1. Mailman, R B

    1. Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum.
      D M Niedzwiecki, L X Cubeddu and R B Mailman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 117-125;
    2. Comparative anticholinergic properties of thioridazine, mesoridazine and sulforidazine.
      D M Niedzwiecki, L X Cubeddu and R B Mailman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 126-133;

  2. Major, T C

    1. PD 122860: a novel dihydropyridine with sodium channel stimulating and calcium channel blocking properties.
      S J Haleen, R P Steffen, I Sircar, T C Major, M D Taylor, T A Pugsley and R E Weishaar
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 22-30;

  3. Malfatto, G

    1. Electrophysiologic effects of ketanserin on canine Purkinje fibers, ventricular myocardium and the intact heart.
      A Zaza, G Malfatto and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 397-405;

  4. Marek, G J

    1. Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule.
      G J Marek, A A Li and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 52-59;
    2. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
      G J Marek, A A Li and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 60-71;

  5. Marquis, O

    1. Evidence for the existence and ionic modulation of platelet-activating factor receptors mediating degranulatory responses in human polymorphonuclear leukocytes.
      O Marquis, C Robaut and I Cavero
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 293-300;

  6. Martyn, J

    1. Intraperitoneal endotoxin but not protein malnutrition shifts d-tubocurarine dose-response curves in mouse gastrocnemius muscle.
      J F Tomera and J Martyn
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 216-220;

  7. McCarty, D R

    1. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
      B M Baron, M W Dudley, D R McCarty, F P Miller, I J Reynolds and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 162-169;

  8. Meier, P J

    1. Multispecificity of Na+-dependent taurocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesicles.
      B Zimmerli, J Valantinas and P J Meier
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 301-308;

  9. Miller, F P

    1. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
      B M Baron, M W Dudley, D R McCarty, F P Miller, I J Reynolds and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 162-169;

  10. Molinoff, P B

    1. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
      B S Schonwetter, R R Luedtke, M P Kung, J Billings, H F Kung and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 110-116;

  11. Mousli, M

    1. Activation of rat peritoneal mast cells by substance P and mastoparan.
      M Mousli, C Bronner, J L Bueb, E Tschirhart, J P Gies and Y Landry
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 329-335;

  12. Murad, F

    1. Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines.
      B M Bennett, D C Leitman, H Schröder, J H Kawamoto, K Nakatsu and F Murad
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 316-323;

  13. Murphy, D L

    1. Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats.
      G Bagdy, K Szemeredi, B Kanyicska and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 72-78;

  14. Myers, R R

    1. Quantitative histologic analysis of local anesthetic-induced injury to rat sciatic nerve.
      M W Kalichman, H C Powell and R R Myers
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 406-413;

N

  1. Nakatsu, K

    1. Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines.
      B M Bennett, D C Leitman, H Schröder, J H Kawamoto, K Nakatsu and F Murad
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 316-323;

  2. Narimatsu, A

    1. Potent stimulation of myofilament force and adenosine triphosphatase activity of canine cardiac muscle through a direct enhancement of troponin C Ca++ binding by MCI-154, a novel cardiotonic agent.
      Y Kitada, M Kobayashi, A Narimatsu and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 272-277;

  3. Navarro, H A

    1. Phosphatidic acid phosphatase in neonatal rat lung: effects of prenatal dexamethasone or terbutaline treatment on basal activity and on responsiveness to beta adrenergic stimulation.
      E M Kudlacz, H A Navarro and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 236-240;

  4. Neely, C F

    1. Adenosine does not mediate the pulmonary vasodilator response of adenosine 5'-triphosphate in the feline pulmonary vascular bed.
      C F Neely, P J Kadowitz, H Lippton, M Neiman and A L Hyman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 170-176;

  5. Neiman, M

    1. Adenosine does not mediate the pulmonary vasodilator response of adenosine 5'-triphosphate in the feline pulmonary vascular bed.
      C F Neely, P J Kadowitz, H Lippton, M Neiman and A L Hyman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 170-176;

  6. Nichols, C L

    1. Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist.
      M M Foreman, R W Fuller, M D Hynes, J S Gidda, C L Nichols, J M Schaus, E C Kornfeld and J A Clemens
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 227-235;

  7. Niedzwiecki, D M

    1. Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum.
      D M Niedzwiecki, L X Cubeddu and R B Mailman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 117-125;
    2. Comparative anticholinergic properties of thioridazine, mesoridazine and sulforidazine.
      D M Niedzwiecki, L X Cubeddu and R B Mailman
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 126-133;

  8. Nohjoh, T

    1. Transport of cefodizime, a novel third generation cephalosporin antibiotic, in isolated rat choroid plexus.
      T Nohjoh, H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 324-328;

O

  1. Ohizumi, Y

    1. Potent stimulation of myofilament force and adenosine triphosphatase activity of canine cardiac muscle through a direct enhancement of troponin C Ca++ binding by MCI-154, a novel cardiotonic agent.
      Y Kitada, M Kobayashi, A Narimatsu and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 272-277;

  2. Ohno, Y

    1. Presynaptic activation of the spinal serotonergic system in the rat by phencyclidine in vitro.
      Y Ohno and J E Warnick
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 177-183;

  3. Okabe, E

    1. Calmodulin and free oxygen radicals interaction with steady-state calcium accumulation and passive calcium permeability of cardiac sarcoplasmic reticulum.
      E Okabe, M Sugihara, K Tanaka, H Sasaki and H Ito
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 286-292;

  4. Ozaki, H

    1. Calcium-independent activation of contractile apparatus in smooth muscle by calyculin-A.
      H Ishihara, H Ozaki, K Sato, M Hori, H Karaki, S Watabe, Y Kato, N Fusetani, K Hashimoto and D Uemura
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 388-396;

P

  1. Pang, P K

    1. Guanine nucleotide binding proteins may modulate gating of calcium channels in vascular smooth muscle. I. Studies with fluoride.
      Y Y Zeng, C G Benishin and P K Pang
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 343-351;
    2. Guanine nucleotide binding proteins may modulate gating of calcium channels in vascular smooth muscle. II. Studies with guanosine 5'-(gamma)triphosphate.
      Y Y Zeng, C G Benishin and P K Pang
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 352-357;

  2. Pauli, G

    1. Characterization of muscarinic receptors in human, guinea pig and rat lung.
      J P Gies, C Bertrand, P Vanderheyden, F Waeldele, P Dumont, G Pauli and Y Landry
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 309-315;

  3. Pechnick, R N

    1. Pharmacokinetic and pharmacodynamic evaluation of phencyclidine and its decadeutero variant.
      A K Cho, M Hiramatsu, R N Pechnick and E Di Stefano
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 210-215;

  4. Pendleton, R G

    1. Studies defining minimal receptor domains for angiotensin II.
      R G Pendleton, G Gessner and E Horner
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 31-36;

  5. Porter, A C

    1. Changes in drinking activity, urine volume and urinary electrolyte excretion after intracerebroventricular administration of diisopropylfluorophosphate.
      M D Dulaney, R W Rockhold, A C Porter, B Hoskins and I K Ho
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 202-209;

  6. Powell, H C

    1. Quantitative histologic analysis of local anesthetic-induced injury to rat sciatic nerve.
      M W Kalichman, H C Powell and R R Myers
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 406-413;

  7. Preston, K L

    1. Drug discrimination in human postaddicts: agonist-antagonist opioids.
      K L Preston, G E Bigelow, W K Bickel and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 184-196;

  8. Pugsley, T A

    1. PD 122860: a novel dihydropyridine with sodium channel stimulating and calcium channel blocking properties.
      S J Haleen, R P Steffen, I Sircar, T C Major, M D Taylor, T A Pugsley and R E Weishaar
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 22-30;

Q

  1. Quast, U

    1. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
      U Quast and N S Cook
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 261-271;

R

  1. Ramsammy, L S

    1. Polyaspartic acid protects against gentamicin nephrotoxicity in the rat.
      L S Ramsammy, C Josepovitz, B P Lane and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 149-153;

  2. Ravens, U

    1. Alpha adrenoceptor stimulation reduces outward currents in rat ventricular myocytes.
      U Ravens, X L Wang and E Wettwer
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 364-370;

  3. Reynolds, I J

    1. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
      B M Baron, M W Dudley, D R McCarty, F P Miller, I J Reynolds and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 162-169;

  4. Robaut, C

    1. Evidence for the existence and ionic modulation of platelet-activating factor receptors mediating degranulatory responses in human polymorphonuclear leukocytes.
      O Marquis, C Robaut and I Cavero
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 293-300;

  5. Rockhold, R W

    1. Changes in drinking activity, urine volume and urinary electrolyte excretion after intracerebroventricular administration of diisopropylfluorophosphate.
      M D Dulaney, R W Rockhold, A C Porter, B Hoskins and I K Ho
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 202-209;

  6. Rodriguez, J V

    1. Vulnerability of the thick ascending limb to glutathione depletion in rat kidney: effects of diuretics and indomethacin.
      A M Torres, J V Rodriguez and M M Elías
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 247-253;

  7. Rosen, M R

    1. Electrophysiologic effects of ketanserin on canine Purkinje fibers, ventricular myocardium and the intact heart.
      A Zaza, G Malfatto and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 397-405;

  8. Rzeszotarski, W J

    1. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
      J W Ferkany, D J Kyle, J Willets, W J Rzeszotarski, M E Guzewska, S R Ellenberger, S M Jones, A I Sacaan, L D Snell and S Borosky
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 100-109;

S

  1. Sacaan, A I

    1. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
      J W Ferkany, D J Kyle, J Willets, W J Rzeszotarski, M E Guzewska, S R Ellenberger, S M Jones, A I Sacaan, L D Snell and S Borosky
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 100-109;

  2. Sasaki, H

    1. Calmodulin and free oxygen radicals interaction with steady-state calcium accumulation and passive calcium permeability of cardiac sarcoplasmic reticulum.
      E Okabe, M Sugihara, K Tanaka, H Sasaki and H Ito
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 286-292;

  3. Sato, K

    1. Calcium-independent activation of contractile apparatus in smooth muscle by calyculin-A.
      H Ishihara, H Ozaki, K Sato, M Hori, H Karaki, S Watabe, Y Kato, N Fusetani, K Hashimoto and D Uemura
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 388-396;

  4. Satoh, N

    1. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
      T Tadano, S Satoh, N Satoh, K Kisara, Y Arai, S K Kim and H Kinemuchi
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 254-260;

  5. Satoh, S

    1. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
      T Tadano, S Satoh, N Satoh, K Kisara, Y Arai, S K Kim and H Kinemuchi
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 254-260;

  6. Sawada, Y

    1. Transport of cefodizime, a novel third generation cephalosporin antibiotic, in isolated rat choroid plexus.
      T Nohjoh, H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 324-328;

  7. Scavone, J M

    1. Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam.
      D J Greenblatt, B L Ehrenberg, J Gunderman, J M Scavone, N T Tai, J S Harmatz and R I Shader
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 134-140;

  8. Schaus, J M

    1. Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist.
      M M Foreman, R W Fuller, M D Hynes, J S Gidda, C L Nichols, J M Schaus, E C Kornfeld and J A Clemens
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 227-235;

  9. Schmidt, C J

    1. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
      B M Baron, M W Dudley, D R McCarty, F P Miller, I J Reynolds and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 162-169;

  10. Schneider, D E

    1. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels.
      T D Bjornsson, D E Schneider and H Berger
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 154-161;

  11. Schnepper, P W

    1. Increased serotonin efflux by a partially oxidized serotonin: tryptamine-4,5-dione.
      J C Chen, P B Crino, P W Schnepper, A C To and L Volicer
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 141-148;

  12. Schonwetter, B S

    1. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
      B S Schonwetter, R R Luedtke, M P Kung, J Billings, H F Kung and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 110-116;

  13. Schröder, H

    1. Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines.
      B M Bennett, D C Leitman, H Schröder, J H Kawamoto, K Nakatsu and F Murad
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 316-323;

  14. Seiden, L S

    1. Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule.
      G J Marek, A A Li and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 52-59;
    2. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
      G J Marek, A A Li and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 60-71;

  15. Shader, R I

    1. Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam.
      D J Greenblatt, B L Ehrenberg, J Gunderman, J M Scavone, N T Tai, J S Harmatz and R I Shader
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 134-140;

  16. Sickels, B D

    1. Evidence that prostaglandins can contract the rat aorta via a novel protein kinase C-dependent mechanism.
      R J Heaslip and B D Sickels
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 44-51;

  17. Sircar, I

    1. PD 122860: a novel dihydropyridine with sodium channel stimulating and calcium channel blocking properties.
      S J Haleen, R P Steffen, I Sircar, T C Major, M D Taylor, T A Pugsley and R E Weishaar
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 22-30;

  18. Slotkin, T A

    1. Phosphatidic acid phosphatase in neonatal rat lung: effects of prenatal dexamethasone or terbutaline treatment on basal activity and on responsiveness to beta adrenergic stimulation.
      E M Kudlacz, H A Navarro and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 236-240;

  19. Snell, L D

    1. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
      J W Ferkany, D J Kyle, J Willets, W J Rzeszotarski, M E Guzewska, S R Ellenberger, S M Jones, A I Sacaan, L D Snell and S Borosky
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 100-109;

  20. Snyder, A M

    1. Analgesic effects of phencyclidine-like drugs in rhesus monkeys.
      C P France, A M Snyder and J H Woods
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 197-201;

  21. Steffen, R P

    1. PD 122860: a novel dihydropyridine with sodium channel stimulating and calcium channel blocking properties.
      S J Haleen, R P Steffen, I Sircar, T C Major, M D Taylor, T A Pugsley and R E Weishaar
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 22-30;

  22. Stevens, C W

    1. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion.
      C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 1-8;

  23. Sugihara, M

    1. Calmodulin and free oxygen radicals interaction with steady-state calcium accumulation and passive calcium permeability of cardiac sarcoplasmic reticulum.
      E Okabe, M Sugihara, K Tanaka, H Sasaki and H Ito
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 286-292;

  24. Sugiyama, Y

    1. Transport of cefodizime, a novel third generation cephalosporin antibiotic, in isolated rat choroid plexus.
      T Nohjoh, H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 324-328;

  25. Suzuki, H

    1. Transport of cefodizime, a novel third generation cephalosporin antibiotic, in isolated rat choroid plexus.
      T Nohjoh, H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 324-328;

  26. Szemeredi, K

    1. Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats.
      G Bagdy, K Szemeredi, B Kanyicska and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 72-78;

T

  1. Tadano, T

    1. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
      T Tadano, S Satoh, N Satoh, K Kisara, Y Arai, S K Kim and H Kinemuchi
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 254-260;

  2. Tai, N T

    1. Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam.
      D J Greenblatt, B L Ehrenberg, J Gunderman, J M Scavone, N T Tai, J S Harmatz and R I Shader
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 134-140;

  3. Tanaka, K

    1. Calmodulin and free oxygen radicals interaction with steady-state calcium accumulation and passive calcium permeability of cardiac sarcoplasmic reticulum.
      E Okabe, M Sugihara, K Tanaka, H Sasaki and H Ito
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 286-292;

  4. Taylor, M D

    1. PD 122860: a novel dihydropyridine with sodium channel stimulating and calcium channel blocking properties.
      S J Haleen, R P Steffen, I Sircar, T C Major, M D Taylor, T A Pugsley and R E Weishaar
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 22-30;

  5. To, A C

    1. Increased serotonin efflux by a partially oxidized serotonin: tryptamine-4,5-dione.
      J C Chen, P B Crino, P W Schnepper, A C To and L Volicer
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 141-148;

  6. Tomera, J F

    1. Intraperitoneal endotoxin but not protein malnutrition shifts d-tubocurarine dose-response curves in mouse gastrocnemius muscle.
      J F Tomera and J Martyn
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 216-220;

  7. Torres, A M

    1. Vulnerability of the thick ascending limb to glutathione depletion in rat kidney: effects of diuretics and indomethacin.
      A M Torres, J V Rodriguez and M M Elías
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 247-253;

  8. Tschirhart, E

    1. Activation of rat peritoneal mast cells by substance P and mastoparan.
      M Mousli, C Bronner, J L Bueb, E Tschirhart, J P Gies and Y Landry
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 329-335;

U

  1. Uemura, D

    1. Calcium-independent activation of contractile apparatus in smooth muscle by calyculin-A.
      H Ishihara, H Ozaki, K Sato, M Hori, H Karaki, S Watabe, Y Kato, N Fusetani, K Hashimoto and D Uemura
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 388-396;

V

  1. Valantinas, J

    1. Multispecificity of Na+-dependent taurocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesicles.
      B Zimmerli, J Valantinas and P J Meier
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 301-308;

  2. Vanderheyden, P

    1. Characterization of muscarinic receptors in human, guinea pig and rat lung.
      J P Gies, C Bertrand, P Vanderheyden, F Waeldele, P Dumont, G Pauli and Y Landry
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 309-315;

  3. Vaughn, D A

    1. Thiazide diuretic receptors: autoradiographic localization in rat kidney with [3H]metolazone.
      K Beaumont, D A Vaughn and D P Healy
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 414-419;

  4. Volicer, L

    1. Increased serotonin efflux by a partially oxidized serotonin: tryptamine-4,5-dione.
      J C Chen, P B Crino, P W Schnepper, A C To and L Volicer
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 141-148;

W

  1. Waeldele, F

    1. Characterization of muscarinic receptors in human, guinea pig and rat lung.
      J P Gies, C Bertrand, P Vanderheyden, F Waeldele, P Dumont, G Pauli and Y Landry
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 309-315;

  2. Wang, X L

    1. Alpha adrenoceptor stimulation reduces outward currents in rat ventricular myocytes.
      U Ravens, X L Wang and E Wettwer
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 364-370;

  3. Warnick, J E

    1. Presynaptic activation of the spinal serotonergic system in the rat by phencyclidine in vitro.
      Y Ohno and J E Warnick
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 177-183;

  4. Watabe, S

    1. Calcium-independent activation of contractile apparatus in smooth muscle by calyculin-A.
      H Ishihara, H Ozaki, K Sato, M Hori, H Karaki, S Watabe, Y Kato, N Fusetani, K Hashimoto and D Uemura
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 388-396;

  5. Weishaar, R E

    1. PD 122860: a novel dihydropyridine with sodium channel stimulating and calcium channel blocking properties.
      S J Haleen, R P Steffen, I Sircar, T C Major, M D Taylor, T A Pugsley and R E Weishaar
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 22-30;

  6. Wells, P G

    1. Modulation of embryonic glutathione reductase and phenytoin teratogenicity by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
      M Wong and P G Wells
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 336-342;

  7. Wettwer, E

    1. Alpha adrenoceptor stimulation reduces outward currents in rat ventricular myocytes.
      U Ravens, X L Wang and E Wettwer
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 364-370;

  8. Willets, J

    1. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
      J W Ferkany, D J Kyle, J Willets, W J Rzeszotarski, M E Guzewska, S R Ellenberger, S M Jones, A I Sacaan, L D Snell and S Borosky
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 100-109;

  9. Williams, J T

    1. Serotonin agonists inhibit synaptic potentials in the rat locus ceruleus in vitro via 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors.
      D H Bobker and J T Williams
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 37-43;

  10. Wong, M

    1. Modulation of embryonic glutathione reductase and phenytoin teratogenicity by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
      M Wong and P G Wells
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 336-342;

  11. Woods, J H

    1. Analgesic effects of phencyclidine-like drugs in rhesus monkeys.
      C P France, A M Snyder and J H Woods
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 197-201;

Y

  1. Yaksh, T L

    1. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion.
      C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 1-8;

  2. Yang, X M

    1. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate.
      X M Yang, Z P Luo and J H Zhou
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 358-363;

Z

  1. Zawilska, J

    1. Catecholamine receptors regulating serotonin N-acetyltransferase activity and melatonin content of chicken retina and pineal gland: D2-dopamine receptors in retina and alpha-2 adrenergic receptors in pineal gland.
      J Zawilska and P M Iuvone
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 86-92;

  2. Zaza, A

    1. Electrophysiologic effects of ketanserin on canine Purkinje fibers, ventricular myocardium and the intact heart.
      A Zaza, G Malfatto and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 397-405;

  3. Zeng, Y Y

    1. Guanine nucleotide binding proteins may modulate gating of calcium channels in vascular smooth muscle. I. Studies with fluoride.
      Y Y Zeng, C G Benishin and P K Pang
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 343-351;
    2. Guanine nucleotide binding proteins may modulate gating of calcium channels in vascular smooth muscle. II. Studies with guanosine 5'-(gamma)triphosphate.
      Y Y Zeng, C G Benishin and P K Pang
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 352-357;

  4. Zhou, J H

    1. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate.
      X M Yang, Z P Luo and J H Zhou
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 358-363;

  5. Zimmerli, B

    1. Multispecificity of Na+-dependent taurocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesicles.
      B Zimmerli, J Valantinas and P J Meier
      Journal of Pharmacology and Experimental Therapeutics July 1989, 250 (1) 301-308;
Back to top

In this issue

Advertisement